Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCTV02 RSV Vaccine in Healthy Adults
NCT06754605Phase 2Recruiting
- Sponsor
- Sinocelltech Group Limited
- Start
- Feb 2025
- Primary completion
- Jul 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of SCTV02 in respiratory syncytial virus infection (RSV), sponsored by Sinocelltech Group Limited. Started Feb 2025; status: recruiting.
02
Drugs
SCTV02
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT06754605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06754605.